World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00440115
Date of registration: 23/02/2007
Primary sponsor: University of Kansas
Public title: Disease Management for Smoking Cessation
Scientific title: Disease Management for Smokers in Rural Primary Care
Date of first enrolment: June 2009
Target sample size: 750
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00440115
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Edward F. Ellerbeck, MD, MPH
Address: 
Telephone:
Email:
Affiliation:  University of Kansas
Key inclusion & exclusion criteria

Inclusion Criteria:

- Over the age of 18

- Reported smoking at least 10 cigarettes per day for at least 25 of the last 30 days

- Speak English

- Their regular physician is a participating physician

- Working home telephone or cellular phone

Exclusion Criteria:

- Women who are pregnant or planning to become pregnant in the next two years

- Plan on moving within two years

- Display signs of dementia or other mental disorders

- Live with a smoker already enrolled



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Smoking Cessation
Intervention(s)
Behavioral: High intensity disease management
Behavioral: Low intensity disease management
Other: Comparison group
Primary Outcome(s)
7-day point prevalence abstinence from cigarettes [Time Frame: 24 months]
Secondary Outcome(s)
Number of quit attempts [Time Frame: 6, 12 18 and 24 months]
Progress in stage of change [Time Frame: 6, 12, 18 and 24 months]
Secondary ID(s)
5 R01 CA101963
5R01CA101963
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
GlaxoSmithKline
National Cancer Institute (NCI)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history